A Comparison of Different Human Papillomavirus tests in PreservCyt versus SurePath in a Referral Population − PREDICTORS 4

Highlights • First comparison of HPV tests in PreservCyt and SurePath, 2 samples from each woman. • Nucleic acid HPV tests showed similar performance in PreservCyt and SurePath. • Manufacturers recommended pre-treatment protocols must be observed.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical virology 2016-09, Vol.82, p.145-151
Hauptverfasser:	Cuzick, Jack, Ahmad, Amar S, Austin, Janet, Cadman, Louise, Ho, Linda, Terry, George, Kleeman, Michelle, Ashdown-Barr, Lesley, Lyons, Deirdre, Stoler, Mark, Szarewski, Anne
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Allergy and Immunology Cervical screening Diagnostic Tests, Routine - methods Early Detection of Cancer - methods Female Human papillomavirus testing Humans Infectious Disease Papillomaviridae - classification Papillomaviridae - genetics Papillomaviridae - isolation & purification Papillomavirus Infections - diagnosis PreservCyt Prospective Studies Sensitivity and Specificity Specimen Handling - methods SurePath ThinPrep Viral Load - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • First comparison of HPV tests in PreservCyt and SurePath, 2 samples from each woman. • Nucleic acid HPV tests showed similar performance in PreservCyt and SurePath. • Manufacturers recommended pre-treatment protocols must be observed.
ISSN:	1386-6532 1873-5967
DOI:	10.1016/j.jcv.2016.06.015